Investments in Taiwan's biotechnology-related industry is expected to grow 15 percent to NT$25 billion this year, the Ministry of Economic Affairs said yesterday.
The growth is in line with the Cabinet's plan to attract a total of NT$100 billion investment in biotech between 2002 and 2007 and to double production output to NT$250 billion.
"Investment was boosted by a total of 91 new local and foreign investors in biotechnological medicine, medical equipment, agricultural technology, cosmetics and nanotechnology," Wang Shu-hui, (
According to Wang, the investment for the first 10 months of this year already climbed to NT$23.49 billion from NT$19.42 billion a year earlier.
Wang attributed the rapid growth to the establishment of several large biotechnology funds, including a NT$2.5 billion investment raised by a joint venture fund between China Development Financial Holding Corp (中華開發金控) and the Cabinet's Development Fund (開發基金). Another fund, Fortune Athena Biotech Fund (瑞銀生化基金), brought in NT$1.4 billion.
Other small and medium-sized investments, including NT$1 billion from ScinoPharm Taiwan Ltd (台灣神隆) and NT$1 billion from state-run Taiwan Sugar Corp (Taisugar, 台糖), were made in the fields of medical research as well as cosmetics.
Several US biotech companies including Epicyte Pharmaceutical Inc, Genemed Biotechnologies Inc, Ancile Pharmaceuticals Inc and Corgentech Inc, have poured NT$3.07 billion into Taiwan's biotech industry in the last few years, according to Industrial Development Bureau.
Despite reportedly high growth in the sector, several pundits warned of serious hurdles blocking the road to Taiwan's biotech development.
The biggest problem, said John Yang (
Taisugar, a state-run enterprise, is allocating NT$20 million each year cooperative projects with Academia Sinica and the Biomedical Engineering Center at the Industrial Technology Research Institute (工研院).
"We are having difficulty transferring [their] innovations into concrete product ideas," he said.
Biologists have begun to encourage local biotech professionals to pool their findings with foreign firms to keep ahead of the technology race.
Chen Yih-ming (
Kuo Shu-shyang (郭書祥), professor of the Development Center for Biotechnology (生物技術開 發中心), said that Taiwan's burgeoning biotech businesses are already lagging behind other countries and only by cooperating with other international businesses can they skip the "learning phrase."
Intel Corp chief executive officer Lip-Bu Tan (陳立武) is expected to meet with Taiwanese suppliers next month in conjunction with the opening of the Computex Taipei trade show, supply chain sources said on Monday. The visit, the first for Tan to Taiwan since assuming his new post last month, would be aimed at enhancing Intel’s ties with suppliers in Taiwan as he attempts to help turn around the struggling US chipmaker, the sources said. Tan is to hold a banquet to celebrate Intel’s 40-year presence in Taiwan before Computex opens on May 20 and invite dozens of Taiwanese suppliers to exchange views
Application-specific integrated circuit designer Faraday Technology Corp (智原) yesterday said that although revenue this quarter would decline 30 percent from last quarter, it retained its full-year forecast of revenue growth of 100 percent. The company attributed the quarterly drop to a slowdown in customers’ production of chips using Faraday’s advanced packaging technology. The company is still confident about its revenue growth this year, given its strong “design-win” — or the projects it won to help customers design their chips, Faraday president Steve Wang (王國雍) told an online earnings conference. “The design-win this year is better than we expected. We believe we will win
Chizuko Kimura has become the first female sushi chef in the world to win a Michelin star, fulfilling a promise she made to her dying husband to continue his legacy. The 54-year-old Japanese chef regained the Michelin star her late husband, Shunei Kimura, won three years ago for their Sushi Shunei restaurant in Paris. For Shunei Kimura, the star was a dream come true. However, the joy was short-lived. He died from cancer just three months later in June 2022. He was 65. The following year, the restaurant in the heart of Montmartre lost its star rating. Chizuko Kimura insisted that the new star is still down
While China’s leaders use their economic and political might to fight US President Donald Trump’s trade war “to the end,” its army of social media soldiers are embarking on a more humorous campaign online. Trump’s tariff blitz has seen Washington and Beijing impose eye-watering duties on imports from the other, fanning a standoff between the economic superpowers that has sparked global recession fears and sent markets into a tailspin. Trump says his policy is a response to years of being “ripped off” by other countries and aims to bring manufacturing to the US, forcing companies to employ US workers. However, China’s online warriors
RSS